Knowledge Center
Patent / Jan 01, 1973
16.beta.-Methyl-17.alpha.-hydroxypregna-1,4,9(11)-triene-3,20-dione and analogs
Source:
GB 1397267
Pregnatrienedione I was prepd. from epoxypregnanetrione II in 7 steps. Thus, II underwent ketalization with HOCH2CH2OH, KBH4 redn., dehydration, Grignard reaction with MeMgBr, and deketalization to give pregnenedione III. III was treated with Br2-HOAc and then debrominated to I.
Also in the Knowledge Center
/ Dec 28, 2016
Continuous production of particles, micro- and/or nanoparticles, particulate amorphous solid dispersions, particulate co-crystals and pharmaceutical compns.
Read more
Scientific Article
/ Oct 23, 2016
Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability
Read more
Scientific Article
/ Aug 30, 2016
Accelerating approval and reducing costs of spray dried drugs through development by design
Read more
Scientific Article